RA CAPITAL MANAGEMENT, L.P. bought SGP
February 9, 2026 · Form 4 insider transaction
RA CAPITAL MANAGEMENT, L.P. bought 3,441,966 shares of SpyGlass Pharma, Inc. at $16.00 per share, a transaction worth $55.07M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus III Fund, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.; Held directly by the Fund.